microdose vs regular dose glp-1 Low-Dose and for Longevity – GLP-1 Microdose

doi: 10.1016/S2213-8587(21)00246-1 21 EdqvistJRawshaniAAdielsMBjorckLLindMSvenssonAMet al

Clinical Effectiveness and Patient Outcomes with Mochi Published data on Mochi specifically is limited, as the platform is privately held and does not report aggregate patient outcomes in peer-reviewed literature

Most platforms require you to complete laboratory work either through their partner labs or by uploading recent results from your primary care physician

Oprea AD, Ostapenko LJ, Sweitzer B, Selzer A, Irizarry-Alvarado JM, Hurtado Andrade MD, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 38.Chung SJ, et al

A new report supports lower GLP-1 levels related to gut microbiome dysregulation @Cell_Metabolism cell.com/cell-metabolis Despite overriding cardiovascular benefit, statins can raise blood glucose and pose an increased risk of Type 2 diabetes, but the mechanism is unclear